Janakiraman Subramanian retweeted
St Luke's precision oncology program reports improved outcomes for patients with @saintlukeskc molecular tumor board-directed therapy at the ESMO conference in Madrid
Janakiraman Subramanian retweeted
Continuing at MSL Arlington VA with Lung Cancer 🫁session with very comprehensive overview from great colleagues @VamsiVelcheti TKI @RamSubraMD IO and @NaglaAKarimMD resistance. An amazing session chairing by my friend Amin Benyounnes @InovaSchar @mecmededucation @OncoAlert
Janakiraman Subramanian retweeted
Very interesting update on Prostate Cancer Precision Oncology from my former colleague Dr. Arif Hussain from @UMBaltimore @UMGCCC at MSL Arlington @RamSubraMD @NaglaAKarimMD @InovaSchar @OncoAlert @isliquidbiopsy @mecmededucation
Janakiraman Subramanian retweeted
Two days of phenomenal #science, #strategy, #DEI, #collaboration, & #friendship at the Annual Meeting of #ESRN #ECRN at Cairo. Enjoying the history and culture of Egypt with these amazing group of #physicians & #scientists.
#lungcancer #diversity #MENASA #LCSM #SCLC #Inclusion – at Cairo, Egypt
Janakiraman Subramanian retweeted
My job makes me meet wonderful people.
In Cairo with @drgandara @NaglaAKarimMD @karenkellymd @RamSubraMD @BrainTumorDoc Phil Mack. Gearing up for discussing strategies about #lungcancer #SCLC #treatment #airpollution #precisionmedicine. #MENASA #Diversity #LCSM @IcahnMountSinai – at Cairo, Egypt
Janakiraman Subramanian retweeted
Our lung cancer session at 2023 #PRIMO Hawaii @medical_cons meeting with @EdgardoSantosMD jorge nieva @RamSubraMD #LCSM @OLACANCER1 @FLASCO_ORG #Immunotherapy #Immunology #lungcancer
Janakiraman Subramanian retweeted
Great talk by @RamSubraMD making the case that The Future of Lung Cancer Screening in High Risk Non-Smokers is already here!
➡️ family history, biomarkers can select non- smokers at risk
#lcsm
@FLASCO_ORG Early Lung Cancer Summit
@LuisERaez1
Janakiraman Subramanian retweeted
we started our 2023 @flasco Lung Early Summit with Drs Henshke, Yankelevitz, Subramanian and Silvestri @OLACANCER1 #lcsm @Latinamd @OncDocMJ #lungcancer
Janakiraman Subramanian retweeted
Join us for the 2023 @flasco Early Lung Cancer Summit, with a special focus on the Challenges of Early Detection: CT Screening, Blood Biomarkers, and more.
@ChristianRolfo @Latinamd @acmoorephd
@OncDocMJ
#lungcancerscreening #lungcancer #liquidbiopsy #lcsm
Janakiraman Subramanian retweeted
Coming this February! Have you signed up yet? | 8th Annual Practical Recommendations in Immuno & Molecular Oncology (PRIMO) Meeting | Honolulu, HI | February 22 – 25, 2023
For more information, click here: primomeeting.org
#PRIMO #oncology #cancerresearch #ce #credits
Janakiraman Subramanian retweeted
Our case report is out #JTOCRR @JTOonline!
Here we describe a patient with KRAS G12C-mutated lung adenocarcinoma and untreated brain metastases who achieved significant clinical and radiographical response to #sotorasib.
https://xitter.gq/t.co/vScFwdEPpV
Janakiraman Subramanian retweeted
Dr. @StephenVLiu presents overview and updates on mgmt of SCLC, a field he has helped to pioneer, at #DCLUNG22. Difficult tumor type to manage but lots of promising therapeutics under development.
Janakiraman Subramanian retweeted
Comprehensive overview on a very complex topic: mechanisms of resistance of TK by @ZPiotrowskaMD . Great talk. #DCLUNG22 @StephenVLiu @Joshua_Reuss @benlevylungdoc @RamSubraMD @JessicaJLinMD @chulkimMD @lcsmchat
Janakiraman Subramanian retweeted
Dr. @RamSubraMD from @InovaSchar will discuss the management of #BRAF and #MET altered lung cancers at #DCLung22 on Saturday October 29. We have several approved targeted agents with novel approaches on the horizon! Full agenda, faculty and registration at medstarhealth.org/lung2022
Janakiraman Subramanian retweeted
Great team with @PatelOncology @EdgardoSantosMD @edgardo_ny @RamSubraMD and many others ! @CancerExpertNow @OLACANCER1 @medical_cons #LCSM #lungcancer
Registration is still open! Be sure to sign up today to join us | 8th Annual Practical Recommendations in Immuno & Molecular Oncology (PRIMO) Meeting | Honolulu, HI | February 22 – 25, 2023
For more information, click here: primomeeting.org
#PRIMO #oncology #ce #credits
Janakiraman Subramanian retweeted
Join us at the in-person #DCLung22 conference on Saturday October 29 to hear all the latest updates on lung cancer management from an engaging expert faculty panel. Don't miss this one-day, @IASLC endorsed, #CME meeting! #LCSM
medstarhealth.org/lung2022
Janakiraman Subramanian retweeted
Join us on Saturday October 29, 2022 for #DCLung22 to hear the latest updates in lung cancer management. This one-day @IASLC endorsed event in Bethesda, MD offers #CME, ANCC, ACPE, IPCE credits and features a stellar multi-disciplinary faculty roster!
medstarhealth.org/lung2022
Janakiraman Subramanian retweeted
We continue disseminating scientific information in cancer care. Please join me at the Master Lecture Series in October with a outstanding group of scientists, clinicians and researchers. WWW.MECCINC.COM. @FLASCO_ORG @ACPinternists @ASCO @edgardo_ny @medical_cons – at Boca Raton, FL
Janakiraman Subramanian retweeted
Replying to @RamSubraMD @EdgardoSantosMD
Ty Dr. Subramanian and ty also for your participation in this important meeting. We need to attack this disease from its early stages.
Janakiraman Subramanian retweeted
#FLASCO Excellent discussion of complexities in diagnosis and management of early stage NSCLC. @ChristianRolfo @LuisERaez1 @Latinamd @EdgardoSantosMD @RamSubraMD @FLASCO_ORG
Great talk, (as always!) by @drgandara on MRD in NSCLC at the @FLASCO_ORG summit on early detection in Miami. Excellent multidisciplinary forum to discuss on Screening. Congrats @LuisERaez1 for the excellent agenda, organization and stellar faculty. @EdgardoSantosMD @Latinamd

















































